UK Biotech Proximagen Raises Record $80 Million ‘Asset Acquisition’ Fund
This article was originally published in The Pink Sheet Daily
Executive Summary
In one of the U.K.’s largest fundraisings, Proximagen avoids paying a discount to its share price. Proceeds will buy CNS pipeline assets.